Medical Applications

In interventional medical devices or non-medical control systems, delays in detection, processing and response to various signals negatively affects overall performance.  Certain human patho-physiological events are good candidates for the application of temporally-advanced waveform detection. For example, with certain types of biomedical signals (e.g. heart, brain) the greater the delay, the more difficult it is to successfully intervene in order to contain or limit a pathological process such as cardiac fibrillation or an epileptic seizure. The earlier the intervention is initiated, the greater the probability of success. SA Technology has potential in early arrhythmia and epileptic seizure detection and intervention.

 

SA Technology may be well suited for medical instruments and treatment devices as well as electrophysiological interfaces used in the detection, acquisition and processing of band-limited analog waveforms produced by the body (e.g., brainwaves such as the EEG and MEG; neuromuscular potentials/EMG (electromyogram); cardiac rhythms/ECG).

 

Demonstrating reliable and consistent temporally advanced detection of electro-physiological waveforms may enable intervention with a pathological event (much) earlier than previously possible. SA detection could also be used to improve the performance of cardiac rhythm management, neurostimulation, neural computer interfaces, neurotherapy applications, radiation therapy and imaging. SAI's initial R&D focus is the application of SAT to the detection of bioelectric signals for potential use in interventional medical applications.

 

In real-time applications, SA may offset signal processing delays associated with the extraction of relevant features thereby improving response times and overall system performance. Additionally, SA Technology, using multiple spectrally tuned bands of single-stage SA circuits in parallel, has the potential to temporally shift overlapping signal elements (artifacts/noise) differentially to allow unmasking of bioelectric signal components of interest. The ability to separate anomalous or artifactual signal constituents based on their spectral content may facilitate earlier detection/intervention.

 

Some potential biomedical applications include real-time artifact detection and correction, neural pacing/seizure suppression, neurofeedback/ neurotherapy, brain-computer/neural interfaces, and electrocardiology. Additionally, SA Technology could enhance the performance of physiologically gated diagnostic and therapeutic applications (such as medical imaging and radiotherapy) by temporally advancing the detection of certain trigger signals thereby improving target and timing accuracy.

 

Various sources of artifacts often lead to unwanted signal components that overlap or mask the electro-physiological signals of interest. Much of the current artifact detection/correction research focuses on reducing the computational load of present artifact-rejection algorithms in order to reduce their processing time.  A number of these techniques operate in the frequency domain over narrow spectral bands.

There is ample evidence that electronic circuitry can be designed to impart nearly constant amplitude gain and advance for a wide variety of biomedical signals. Based on direct experimental results, the overall temporal advance can be increased by cascading multiple SA circuit stages, provided that signal distortion and any introduced artifacts are kept to a minimum through appropriate and judicious use of filtering and signal conditioning.

The Medical Market Analysis for Signal Advance Applications is highly favorable; or find out more on Industrial Applications of SAT.

Signal Advance, Inc. ©  2016

 

 

The Company has an Effective S-1 Registration filed with the Securities Exchange Commission.

Trading as SIGL